Please note that HSBI-PUB no longer supports Internet Explorer versions 8 or 9 (or earlier).
We recommend upgrading to the latest Internet Explorer, Google Chrome, or Firefox.
1 Publikation
2009 | Artikel | FH-PUB-ID: 6659
Lukas, Carsten, Barbara Bellenberg, Horst K. Hahn, Jan Rexilius, Robert Drescher, Kerstin Hellwig, Odo Köster, and Sebastian Schimrigk. “Benefit of Repetitive Intrathecal Triamcinolone Acetonide Therapy in Predominantly Spinal Multiple Sclerosis: Prediction by Upper Spinal Cord Atrophy.” Therapeutic Advances in Neurological Disorders 2, no. 6 (2009): 349–55. https://doi.org/10.1177/1756285609343480.
HSBI-PUB
| DOI